Endovion

Drug Profile

Endovion

Alternative Names: NS 3728

Latest Information Update: 31 Aug 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator NeuroSearch
  • Class Antineoplastics; Eye disorder therapies
  • Mechanism of Action Chloride channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Age-related macular degeneration; Cancer; Sickle cell anaemia

Most Recent Events

  • 31 Aug 2016 Chemical structure information added
  • 12 Jul 2016 Saniona in-licenses endovion from NeuroSearch before July 2016 (Saniona e-mail communication; July 2016)
  • 03 Jun 2016 Saniona plans a phase II trial for Colorectal cancer (Second-line therapy or greater, Combination therapy)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top